nitroglycerin has been researched along with rofecoxib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdellatif, KR; Chen, QH; Chowdhury, MA; Dong, Y; Knaus, EE | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bayindir, P; Bayturan, O; Ekmekçi, C; Tikiz, C; Tikiz, H; Utük, O | 1 |
1 trial(s) available for nitroglycerin and rofecoxib
Article | Year |
---|---|
Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease.
Topics: Aged; Brachial Artery; Coronary Artery Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Lactones; Male; Membrane Proteins; Middle Aged; Nitroglycerin; Prostaglandin-Endoperoxide Synthases; Sulfones; Vasodilation; Vasodilator Agents | 2005 |
2 other study(ies) available for nitroglycerin and rofecoxib
Article | Year |
---|---|
Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
Topics: Acrylates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Esters; Nitric Oxide; Nitric Oxide Donors; Prodrugs; Rats; Serum; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |